Moreover, SGLT2 inhibitors also enhance treatment efficacy by improving the factors involved in the pathogenesis of diabetes including hyperglycemia, hypertension, and hyperlipidemia [2]. This evidence concerns the gene SLC5A2 and diabetes mellitus.